(JKL) iShares Morningstar - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US4642887032
JKL: Small-Cap, Stocks, Equities, Securities, Assets
The iShares Morningstar Small-Cap Value ETF (JKL) is designed to mirror the performance of the Morningstar US Small Cap Broad Value Extended Index, comprising small-cap US equities that exhibit strong value characteristics. By investing at least 90% of its assets in the underlying indexs securities or depositary receipts, JKL provides investors with exposure to a diversified portfolio of small-cap value stocks.
The underlying index is constructed using Morningstars proprietary methodology, which identifies small-cap companies with above-average value characteristics. This approach enables JKL to capture the performance of undervalued small-cap stocks, potentially offering investors a means to capitalize on the value premium. With a focus on the US small-cap value segment, JKL may be an attractive option for investors seeking to diversify their portfolios and tap into the potential for long-term growth in this market niche.
Analyzing the available technical data, JKLs recent price action suggests a potential bullish trend. The ETFs last price is above both its 20-day and 50-day simple moving averages (SMA20 and SMA50), indicating a short-term uptrend. However, the 200-day simple moving average (SMA200) is still above the current price, suggesting that the long-term trend is still bearish. The Average True Range (ATR) indicates moderate volatility, with a 2.93% daily average price movement.
Considering the fundamental data, JKLs Assets Under Management (AUM) stand at $426.89 million, indicating a relatively modest but still significant presence in the market. Given the current technical and fundamental landscape, a forecast for JKL could be as follows: if the ETF continues to trade above its SMA20 and SMA50, and the overall market sentiment remains positive, JKL may potentially test its 52-week high of $68.81 in the coming months. Conversely, if the long-term bearish trend reasserts itself, JKL may revisit its SMA200 at $61.88 or even lower. Investors should closely monitor the ETFs price action and adjust their strategies accordingly.
Additional Sources for JKL ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
JKL ETF Overview
Market Cap in USD | 440m |
Category | Small Value |
TER | 0.06% |
IPO / Inception | 2004-06-28 |
JKL ETF Ratings
Growth Rating | 53.9 |
Fundamental | - |
Dividend Rating | 17.3 |
Rel. Strength | -4.06 |
Analysts | - |
Fair Price Momentum | 58.22 USD |
Fair Price DCF | - |
JKL Dividends
Dividend Yield 12m | 1.67% |
Yield on Cost 5y | 3.30% |
Annual Growth 5y | -14.70% |
Payout Consistency | 90.7% |
Payout Ratio | % |
JKL Growth Ratios
Growth Correlation 3m | 37.4% |
Growth Correlation 12m | -9.2% |
Growth Correlation 5y | 71.4% |
CAGR 5y | 14.28% |
CAGR/Max DD 5y | 0.56 |
Sharpe Ratio 12m | -0.33 |
Alpha | -3.78 |
Beta | 0.931 |
Volatility | 20.42% |
Current Volume | 10.3k |
Average Volume 20d | 12.1k |
As of June 21, 2025, the stock is trading at USD 59.85 with a total of 10,341 shares traded.
Over the past week, the price has changed by +0.62%, over one month by -1.53%, over three months by -0.53% and over the past year by +6.12%.
Partly, yes. Based on ValueRay´s Analyses, iShares Morningstar (NYSE ARCA:JKL) is currently (June 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 53.87 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of JKL is around 58.22 USD . This means that JKL is currently overvalued and has a potential downside of -2.72%.
iShares Morningstar has no consensus analysts rating.
According to our own proprietary Forecast Model, JKL iShares Morningstar will be worth about 65.5 in June 2026. The stock is currently trading at 59.85. This means that the stock has a potential upside of +9.46%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 65.5 | 9.5% |